Scleroderma and interstitial lung disease: The Lancet Respiratory Medicine: July 25, 2016
11 Minuten
Podcast
Podcaster
Beschreibung
vor 9 Jahren
Donald Tashkin discusses a clinical trial for the treatment of
scleroderma-related interstitial lung disease, a rare but
devastating condition.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Weitere Episoden
11 Minuten
vor 5 Monaten
15 Minuten
vor 5 Monaten
19 Minuten
vor 5 Monaten
12 Minuten
vor 5 Monaten
12 Minuten
vor 6 Monaten
In Podcasts werben
Kommentare (0)